Cindy Vincent

With mammalian cell line engineering and flexible cGMP production scale up to 4,000L in single-use bioreactors, Catalent Biologics offers increased flexibility & manufacturing scale to support customer growth. This article features Justin Koepsel, PhD, MBA where he discusses how our Madison facility plays a role in Wisconsin’s biopharmaceutical manufacturing sector. #Wisconsin #biotech https://ow.ly/7pEP50SxU6A https://dy.si/9mDcBP

7

Comprehensive biomarker testing like CGIP can uncover key molecular and immune targets in a patient’s tumor. This allows for effective personalized treatment options and potential clinical trial opportunities for patients with #cancer. Learn more: https://lnkd.in/emf2yydA

6

There are special trains and there are more standard career journeys. 📢 Chick here and apply now to catch your high speed train! 🌟 #ClinicalTrials #withcustomersinmind #makinganimpact #leadership

66

1 Comment

🌍 A Journey of Growth and Impact: Thermo Fisher Scientific 🌍 Discover the transformative journey of Alexis R. Director of EHS and Sustainability at Thermo Fisher Scientific. He touched on the opportunities for growth, the importance of compliance and safety, and the impact on making the world healthier, cleaner, and safer. Click on the link for the full article and be inspired by Thermo Fisher's mission. #LifeAtThermoFisher

3

The combination product device development pathway is complex and risky. Scale up a combination product without adding risk. https://bit.ly/4abJDII #Combinationproducts #DrugDevelopment #MedicalDevices

1

📢 Breaking News: Agilent Technologies to Acquire North American CDMO BIOVECTRA! 🌟🔬 Agilent Technologies is set to expand its biopharma capabilities with the acquisition of BIOVECTRA, a leading North American CDMO. This strategic move aims to enhance Agilent's offering in the growing biopharmaceutical market. Key Highlights: 🔹 Enhanced Capabilities: The acquisition will bolster Agilent's manufacturing and development services, particularly in complex and high-value therapeutic areas. 🔹 Strategic Expansion: This move aligns with Agilent's long-term strategy to diversify and strengthen its presence in the biopharma sector. 🔹 Innovation Boost: BIOVECTRA’s expertise in microbial fermentation, complex chemistry, and biologics will complement Agilent's existing technologies, driving innovation and growth. 📅 The transaction is expected to close by the end of 2024, pending regulatory approvals. “We are excited to welcome BIOVECTRA to the Agilent family. This acquisition will accelerate our ability to provide comprehensive solutions to our biopharma customers,” said Mike McMullen, CEO of Agilent. #Acquisition #Biopharma #Agilent #BIOVECTRA #Biotechnology #CDMO #HealthcareInnovation #LifeSciences #StrategicExpansion

2

1 Comment

Vaya Group is proud to have played a pivotal role in the creation and application of the 360 assessment for Takeda's Level Up development program for first-line sales leaders. Let's start a conversation today and see how we can help your organization assess and develop leaders. #assessment #leadership #salesleaders #coaching #leadershipprogram

22

Check out this blog post written by West expert, Abigail Hisler on simplifying biologics drug packaging: transitioning from vial to prefilled syringe. https://bit.ly/462zIDK

2

🌍 A Journey of Growth and Impact: Thermo Fisher Scientific 🌍 Discover the transformative journey of Alexis R. Director of EHS and Sustainability at Thermo Fisher Scientific. He touched on the opportunities for growth, the importance of compliance and safety, and the impact on making the world healthier, cleaner, and safer. Click on the link for the full article and be inspired by Thermo Fisher's mission. #LifeAtThermoFisher

1

🚀 Danaher Corporation Surpasses Q2 Earnings Estimates Amid Bioprocessing Momentum 🧬 Exciting news from Danaher Corp (NYSE: DHR)! The life sciences giant has reported strong Q2 earnings, beating estimates thanks to sustained momentum in their bioprocessing business. 📈 🔍 Key Highlights: -Sales: $5.743 billion, a 3% YoY decrease but above the $5.59 billion consensus. -Adjusted EPS: $1.72, surpassing the expected $1.57. -Operating Cash Flow: $1.4 billion. -Non-GAAP Free Cash Flow: $1.1 billion. -Operating Margin: 27.3%, higher than the 26% guidance. 🧪 Segment Performance: -Biotechnology Sales: Down 9%, from $1.86 billion to $1.71 billion. -Life Sciences Sales: Slightly down from $1.79 billion to $1.77 billion. -Diagnostic Sales: Increased from $2.23 billion to $2.26 billion. 🎯 CEO Insights: "We were particularly pleased with the sustained positive momentum in our bioprocessing business and strong performance at Cepheid, which we believe gained market share in molecular testing again this quarter." - Rainer Blair, President & CEO. 📊 Future Guidance: -Fiscal Year 2024: Non-GAAP core revenue to decline in low-single digits. Q3 2024: Non-GAAP core revenue expected to be down in the low-single digits. -Operating Margin: Projected at 26% for Q3, reaffirming FY 2024 margin guidance of ~29%. -Bioprocessing Core Revenue: Anticipated to decline in low single digits. Cepheid Respiratory Revenues: Forecasted to be around $1.6 billion for 2024. 💹 Market Reaction: DHR stock surged by 7.20%, reaching $268.96 on Tuesday. Stay tuned for more updates as Danaher continues to drive innovation in the life sciences sector! 🌟 #EarningsReport #LifeSciences #Bioprocessing #Danaher #FinancialResults #StockMarket #HealthcareInnovation #Q2Results #Biotechnology #Diagnostics

2

1 Comment

📢 More exciting news for #antibiotics! Qpex Biopharma, a Shionogi & Co., Ltd , received an additional $10m from the Biomedical Advanced Research and Development Authority (BARDA) to advance antibiotic clinical development addressing drug-resistant infections. ​ ​​ Read here all about it ➡  https://lnkd.in/erGXEHXE ​

7

Demonstrating the technical leadership of SK pharmteco! 🧬 Catch up with our team at ASGCT to discuss how SKPT can support your #cellandgene development!

9

1 Comment

Come join Agilent for a monthly webinar starting next month and running thru October. Hear from our technical experts and get practical knowledge on improving your chromatography. Whether you are a seasoned veteran or a beginner, our GC, and GC/MS Webinar Series will help to make you a better chromatographer so you get the reproducible results you need to make your lab more productive. You will leave with actionable tips and tricks you can apply immediately in your lab. For attending you'll receive a coupon for a 25% discount on any Agilent GC and LC Columns, Sample Prep Products and your most often used Chromatography and Spectroscopy Supplies*. Topics: May 17 - Analysis of Permanent Gases: More Challenging Than You Might Think June 20 - Take the Trouble Out of Troubleshooting: Gas Chromatography July 18 - Agilent GC/MS Solutions for Cannabis and Hemp Testing August 30 - Overwhelmed with Too Many GC Column Options? Let Us Help September 28 - Tips and Tricks: Best Practices for Column Installation and Care of GC Columns October 18 - Techniques for Avoiding Unexpected Problems in LC and GC Analysis Each webinar will start at 8:00 a.m. PT and will be approximately one hour long with a Q&A portion at the end. * Some restrictions apply

30

1 Comment

Leverage quick study starts to gain a better understanding of the metabolism and pharmacokinetic profile of your compounds. We offer DMPK and ADME testing solutions at the scale, accessibility and speed you require to make rapid, informed decisions. Learn more or book your study today. #ADME #FastStudyStarts #Pharmacokinetics #Metabolism #DMPK

1

One for my Diagnostic network - I'm interested to hear thoughts on the FDA's plan to bring LDTs into its regulatory fold over the next 4 years? What impact is this going to have on the market? 👇 ✏ #FDA #IVD #diagnostics #LDTs #labdevelopedtests #IVDS

2